https://timesofindia.indiatimes.com/videos/lifestyle/health-fitness/three-medicine-combination-therapy-is-beneficial-in-patients-with-high-risk-cll-study/videoshow/96170684.cms
According to a new phase 2 clinical trial led by Dana-Farber Cancer Institute doctors, a three-medicine combination that drove chronic lymphocytic leukaemia (CLL) patients into profound remissions in a clinical study is very beneficial in patients with high-r…
Create an account or login to join the discussion